Leukemia Clinical Trials in Pittsburgh

Showing 821-822 of 822 trials

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

NCT00131313

This research study measures the safety and efficacy of the combination of three drugs that are approved, Nipent, Rituxan and Cytoxan in the treatment of Chronic Lymphocytic Leukemia (CLL). These drugs are being given together for investigational purposes as the specific combination of these three drugs has not been approved for treatment of CLL by the FDA.

Chronic Lymphocytic Leukemia

East Valley Hematology and Oncology Medical Group180 participantsStarted Jan 2003

Muscle Shoals, Alabama, United States • Burbank, California, United States • Concord, California, United States +49 more locations

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Leukemia Trials in Other Cities

CP-481,715 Nickel Allergy Study.

Other Conditions in Pittsburgh